Global Connected Injectable Drug Delivery Devices Market Insights, Forecast to 2025

Description

Connected injectable drug delivery devices reminds and records patients dosing pattern and makes it accessible to healthcare professionals for significant understanding about the patient condition.
Growing prevalence of chronic diseases like diabetes, cardiovascular disease, and cancer coupled with increasing compliance to the treatment owing to use of the Connected injectable drug delivery devices.
The global Connected Injectable Drug Delivery Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Connected Injectable Drug Delivery Devices market based on company, product type, end user and key regions.

This report studies the global market size of Connected Injectable Drug Delivery Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Connected Injectable Drug Delivery Devices in these regions.
This research report categorizes the global Connected Injectable Drug Delivery Devices market by top players/brands, region, type and end user. This report also studies the global Connected Injectable Drug Delivery Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Phillips-Medisize
West Pharmaceutical Services
Biocorp
Aterica
Unilife
Propeller Health
Haselmeier
SHL
Becton Dickinson
Baxter International
Scandinavian Health
Ypsomed
Terumo Medical
Schott
Owen Mumford
Antares Pharma
Zogenix

Market size by Product
Conventional
Self-Injection
Others
Market size by End User
Diabetes
Cardiovascular Diseases
Autoimmune Diseases
Hormones Replacement
Neurology
Addiction
Respiratory Diseases
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Connected Injectable Drug Delivery Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Connected Injectable Drug Delivery Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Connected Injectable Drug Delivery Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Connected Injectable Drug Delivery Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Connected Injectable Drug Delivery Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Connected Injectable Drug Delivery Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Study Coverage
1.1 Connected Injectable Drug Delivery Devices Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Connected Injectable Drug Delivery Devices Market Size Growth Rate by Product
1.4.2 Conventional
1.4.3 Self-Injection
1.4.4 Others
1.5 Market by End User
1.5.1 Global Connected Injectable Drug Delivery Devices Market Size Growth Rate by End User
1.5.2 Diabetes
1.5.3 Cardiovascular Diseases
1.5.4 Autoimmune Diseases
1.5.5 Hormones Replacement
1.5.6 Neurology
1.5.7 Addiction
1.5.8 Respiratory Diseases
1.5.9 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Connected Injectable Drug Delivery Devices Market Size
2.1.1 Global Connected Injectable Drug Delivery Devices Revenue 2014-2025
2.1.2 Global Connected Injectable Drug Delivery Devices Sales 2014-2025
2.2 Connected Injectable Drug Delivery Devices Growth Rate by Regions
2.2.1 Global Connected Injectable Drug Delivery Devices Sales by Regions
2.2.2 Global Connected Injectable Drug Delivery Devices Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Connected Injectable Drug Delivery Devices Sales by Manufacturers
3.1.1 Connected Injectable Drug Delivery Devices Sales by Manufacturers
3.1.2 Connected Injectable Drug Delivery Devices Sales Market Share by Manufacturers
3.1.3 Global Connected Injectable Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
3.2 Connected Injectable Drug Delivery Devices Revenue by Manufacturers
3.2.1 Connected Injectable Drug Delivery Devices Revenue by Manufacturers (2014-2019)
3.2.2 Connected Injectable Drug Delivery Devices Revenue Share by Manufacturers (2014-2019)
3.3 Connected Injectable Drug Delivery Devices Price by Manufacturers
3.4 Connected Injectable Drug Delivery Devices Manufacturing Base Distribution, Product Types
3.4.1 Connected Injectable Drug Delivery Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Connected Injectable Drug Delivery Devices Product Type
3.4.3 Date of International Manufacturers Enter into Connected Injectable Drug Delivery Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Connected Injectable Drug Delivery Devices Sales by Product
4.2 Global Connected Injectable Drug Delivery Devices Revenue by Product
4.3 Connected Injectable Drug Delivery Devices Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Connected Injectable Drug Delivery Devices Breakdown Data by End User

6 North America
6.1 North America Connected Injectable Drug Delivery Devices by Countries
6.1.1 North America Connected Injectable Drug Delivery Devices Sales by Countries
6.1.2 North America Connected Injectable Drug Delivery Devices Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Connected Injectable Drug Delivery Devices by Product
6.3 North America Connected Injectable Drug Delivery Devices by End User

7 Europe
7.1 Europe Connected Injectable Drug Delivery Devices by Countries
7.1.1 Europe Connected Injectable Drug Delivery Devices Sales by Countries
7.1.2 Europe Connected Injectable Drug Delivery Devices Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Connected Injectable Drug Delivery Devices by Product
7.3 Europe Connected Injectable Drug Delivery Devices by End User

8 Asia Pacific
8.1 Asia Pacific Connected Injectable Drug Delivery Devices by Countries
8.1.1 Asia Pacific Connected Injectable Drug Delivery Devices Sales by Countries
8.1.2 Asia Pacific Connected Injectable Drug Delivery Devices Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Connected Injectable Drug Delivery Devices by Product
8.3 Asia Pacific Connected Injectable Drug Delivery Devices by End User

9 Central & South America
9.1 Central & South America Connected Injectable Drug Delivery Devices by Countries
9.1.1 Central & South America Connected Injectable Drug Delivery Devices Sales by Countries
9.1.2 Central & South America Connected Injectable Drug Delivery Devices Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Connected Injectable Drug Delivery Devices by Product
9.3 Central & South America Connected Injectable Drug Delivery Devices by End User

10 Middle East and Africa
10.1 Middle East and Africa Connected Injectable Drug Delivery Devices by Countries
10.1.1 Middle East and Africa Connected Injectable Drug Delivery Devices Sales by Countries
10.1.2 Middle East and Africa Connected Injectable Drug Delivery Devices Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Connected Injectable Drug Delivery Devices by Product
10.3 Middle East and Africa Connected Injectable Drug Delivery Devices by End User

11 Company Profiles
11.1 Phillips-Medisize
11.1.1 Phillips-Medisize Company Details
11.1.2 Company Business Overview
11.1.3 Phillips-Medisize Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Phillips-Medisize Connected Injectable Drug Delivery Devices Products Offered
11.1.5 Phillips-Medisize Recent Development
11.2 West Pharmaceutical Services
11.2.1 West Pharmaceutical Services Company Details
11.2.2 Company Business Overview
11.2.3 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
11.2.4 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Products Offered
11.2.5 West Pharmaceutical Services Recent Development
11.3 Biocorp
11.3.1 Biocorp Company Details
11.3.2 Company Business Overview
11.3.3 Biocorp Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Biocorp Connected Injectable Drug Delivery Devices Products Offered
11.3.5 Biocorp Recent Development
11.4 Aterica
11.4.1 Aterica Company Details
11.4.2 Company Business Overview
11.4.3 Aterica Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Aterica Connected Injectable Drug Delivery Devices Products Offered
11.4.5 Aterica Recent Development
11.5 Unilife
11.5.1 Unilife Company Details
11.5.2 Company Business Overview
11.5.3 Unilife Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Unilife Connected Injectable Drug Delivery Devices Products Offered
11.5.5 Unilife Recent Development
11.6 Propeller Health
11.6.1 Propeller Health Company Details
11.6.2 Company Business Overview
11.6.3 Propeller Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Propeller Health Connected Injectable Drug Delivery Devices Products Offered
11.6.5 Propeller Health Recent Development
11.7 Haselmeier
11.7.1 Haselmeier Company Details
11.7.2 Company Business Overview
11.7.3 Haselmeier Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Haselmeier Connected Injectable Drug Delivery Devices Products Offered
11.7.5 Haselmeier Recent Development
11.8 SHL
11.8.1 SHL Company Details
11.8.2 Company Business Overview
11.8.3 SHL Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
11.8.4 SHL Connected Injectable Drug Delivery Devices Products Offered
11.8.5 SHL Recent Development
11.9 Becton Dickinson
11.9.1 Becton Dickinson Company Details
11.9.2 Company Business Overview
11.9.3 Becton Dickinson Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Becton Dickinson Connected Injectable Drug Delivery Devices Products Offered
11.9.5 Becton Dickinson Recent Development
11.10 Baxter International
11.10.1 Baxter International Company Details
11.10.2 Company Business Overview
11.10.3 Baxter International Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Baxter International Connected Injectable Drug Delivery Devices Products Offered
11.10.5 Baxter International Recent Development
11.11 Scandinavian Health
11.12 Ypsomed
11.13 Terumo Medical
11.14 Schott
11.15 Owen Mumford
11.16 Antares Pharma
11.17 Zogenix

12 Future Forecast
12.1 Connected Injectable Drug Delivery Devices Market Forecast by Regions
12.1.1 Global Connected Injectable Drug Delivery Devices Sales Forecast by Regions 2019-2025
12.1.2 Global Connected Injectable Drug Delivery Devices Revenue Forecast by Regions 2019-2025
12.2 Connected Injectable Drug Delivery Devices Market Forecast by Product
12.2.1 Global Connected Injectable Drug Delivery Devices Sales Forecast by Product 2019-2025
12.2.2 Global Connected Injectable Drug Delivery Devices Revenue Forecast by Product 2019-2025
12.3 Connected Injectable Drug Delivery Devices Market Forecast by End User
12.4 North America Connected Injectable Drug Delivery Devices Forecast
12.5 Europe Connected Injectable Drug Delivery Devices Forecast
12.6 Asia Pacific Connected Injectable Drug Delivery Devices Forecast
12.7 Central & South America Connected Injectable Drug Delivery Devices Forecast
12.8 Middle East and Africa Connected Injectable Drug Delivery Devices Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Connected Injectable Drug Delivery Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Choose License Type

Checkout Inquiry Sample